Allison Claas
Associate Director Novartis AG
Seminars
Tuesday 27th October 2026
Modelling Targeted Protein Degradation from Cells to the Clinic
5:00 pm
- Describe a mechanistic modelling framework for targeted protein degradation linking drug PK to target and ligase biology
- Demonstrates model applicability to key TPD questions in different phases preclinical development
- Includes a case study the utility of modelling alongside experimentation to inform project strategy and go/no-go decisions
